July 22, 2025

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a Potential 39.62% Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specializes in medical devices with a focus on surgical instruments, neurosurgical, and wound care products. As the..

Opko Health, Inc. (OPK): Investor Outlook and Potential Upside of 185%

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, operates within the diagnostics and research industry. With a market capitalization of $1.11 billion, Opko Health is carving..

Pacira BioSciences, Inc. (PCRX)

⚠️ No article content returned.

..

Disc Medicine, Inc. (IRON) Stock Analysis: Potential 63.78% Upside Captivates Investor Interest

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, is garnering significant attention from investors, distinguished by its robust market cap of $2.06 billion. With a focus..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 30.92% Upside Potential Beckons Investors

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector’s medical instruments and supplies industry, presents a compelling case for investors looking for growth opportunities. With a market..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 56% Potential Upside Amid Healthcare’s Digital Evolution

Evolent Health, Inc. (NYSE: EVH), a prominent player in the health information services industry, is gaining attention from investors with a compelling potential upside of 56.05%. This figure emerges from..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 53% Upside Potential in the Thriving Eyecare Market

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector as a dynamic player specializing in ophthalmic pharmaceutical products. With a market capitalization of $1.36 billion, the Nashville-based company is..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 97% Upside in Biotechnology

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is emerging as a compelling player in the biotechnology sector, capturing investor attention with an impressive potential upside of 97.38% based on current analyst ratings...

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings Signal 77.76% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) is emerging as a captivating opportunity for investors seeking exposure in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 52.9% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a notable player in the healthcare sector, specializing in the development, manufacturing, and marketing of generic and proprietary injectable, inhalation, and intranasal products. With..

Janux Therapeutics (JANX) Stock Analysis: Unveiling a 222% Upside Potential in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents a compelling opportunity. This San Diego-based company is making strides in the realm of..

Establishment Labs Holdings Inc (ESTA) Investor Outlook: Navigating a 27.93% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA) is a name that has been making waves in the medical device sector, particularly within the niche of aesthetic and reconstructive surgery solutions. With..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 40.71% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) is positioning itself as a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, the company has carved..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential Upside of Nearly 78%

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, is dedicated to providing cutting-edge diagnostic and research services with a particular focus on cancer-related testing. Based in Fort..

Viridian Therapeutics, Inc. (VRDN): Analyst Consensus Reveals 128% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is creating a buzz in the biotechnology sector with its focus on developing innovative treatments for serious and rare diseases. With its current pipeline, the..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring an 86.34% Potential Upside Amid Analyst Optimism

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in diagnostic testing solutions, is capturing investor attention with its intriguing potential upside of 86.34%. Despite the current..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: Exploring a Potential 166% Upside

For investors with an appetite for the healthcare sector, Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents an intriguing opportunity with its potential upside of 166.15%. As a clinical-stage biopharmaceutical firm, Mineralys..

Progyny, Inc. (PGNY) Stock Analysis: Strong Growth Potential with 16.61% Upside

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, is making waves in the healthcare plans industry with its innovative approach to fertility and family-building benefits. As a..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Investor Outlook with 93% Potential Upside

For individual investors seeking opportunities in the healthcare sector, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling case with its significant potential upside of 93.42%. As a leader in..

Agios Pharmaceuticals, Inc. (AGIO) Investor Outlook: Analyzing a 29.54% Potential Upside in Biotech Innovation

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a pioneering force in the biotechnology sector, is capturing investor attention with its promising growth potential and innovative approach to treating rare diseases. Headquartered in..

Search

Funds

July 22, 2025

Search

Funds

July 22, 2025

FTSE 100

Funds